<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:68ad79cf-e17b-4efb-b976-4b74898718ca,g:223b7bb8-240b-417f-a0c9-ceb7c13c8727,d:9eb0b2fe6daa4b3b9b37743618365426--><html xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2021" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cnce-20220303</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i9531e69443c44d5d8ea097081e2ea495_D20220303-20220303" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjllYjBiMmZlNmRhYTRiM2I5YjM3NzQzNjE4MzY1NDI2L3NlYzo5ZWIwYjJmZTZkYWE0YjNiOWIzNzc0MzYxODM2NTQyNl80L2ZyYWc6ZWNiMjUzNmNmODhhNGU2YWI3ZjJmOWQ1MTJiNDMyYTMvdGFibGU6MGIyNWRjYTc0ZGJkNDhlMDk0ZGE1NWZhYzI3ZTRjZTQvdGFibGVyYW5nZTowYjI1ZGNhNzRkYmQ0OGUwOTRkYTU1ZmFjMjdlNGNlNF8xLTEtMS0xLTEzOTE2_834c0ad6-99c2-4b06-b7be-da0f553cc30d">0001367920</ix:nonNumeric><ix:nonNumeric contextRef="i9531e69443c44d5d8ea097081e2ea495_D20220303-20220303" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjllYjBiMmZlNmRhYTRiM2I5YjM3NzQzNjE4MzY1NDI2L3NlYzo5ZWIwYjJmZTZkYWE0YjNiOWIzNzc0MzYxODM2NTQyNl80L2ZyYWc6ZWNiMjUzNmNmODhhNGU2YWI3ZjJmOWQ1MTJiNDMyYTMvdGFibGU6MGIyNWRjYTc0ZGJkNDhlMDk0ZGE1NWZhYzI3ZTRjZTQvdGFibGVyYW5nZTowYjI1ZGNhNzRkYmQ0OGUwOTRkYTU1ZmFjMjdlNGNlNF8yLTEtMS0xLTEzOTE2_89112313-31b2-4559-b49d-264d83165bfa">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cnce-20220303.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i9531e69443c44d5d8ea097081e2ea495_D20220303-20220303"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367920</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-03</xbrli:startDate><xbrli:endDate>2022-03-03</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i9eb0b2fe6daa4b3b9b37743618365426_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:13pt;font-weight:700;line-height:120%">_________________________________</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i9531e69443c44d5d8ea097081e2ea495_D20220303-20220303" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjllYjBiMmZlNmRhYTRiM2I5YjM3NzQzNjE4MzY1NDI2L3NlYzo5ZWIwYjJmZTZkYWE0YjNiOWIzNzc0MzYxODM2NTQyNl8xL2ZyYWc6YTM5M2Y1ODY2NGMxNDMwYWE1MWMxZWNhN2RiZTk2YTMvdGV4dHJlZ2lvbjphMzkzZjU4NjY0YzE0MzBhYTUxYzFlY2E3ZGJlOTZhM18yNzQw_0376bbfe-b044-4dbe-8c8b-13ff0789252b">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:13pt;font-weight:700;line-height:120%">_________________________________</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Pursuant to Section&#160;13 or 15(d) of the Securities Exchange Act of 1934</span></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="i9531e69443c44d5d8ea097081e2ea495_D20220303-20220303" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjllYjBiMmZlNmRhYTRiM2I5YjM3NzQzNjE4MzY1NDI2L3NlYzo5ZWIwYjJmZTZkYWE0YjNiOWIzNzc0MzYxODM2NTQyNl8xL2ZyYWc6YTM5M2Y1ODY2NGMxNDMwYWE1MWMxZWNhN2RiZTk2YTMvdGV4dHJlZ2lvbjphMzkzZjU4NjY0YzE0MzBhYTUxYzFlY2E3ZGJlOTZhM18xNjQ5MjY3NDQ0NDEx_52da2b14-28ba-428f-a14f-1de4353c003d">March&#160;3, 2022</ix:nonNumeric></span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9531e69443c44d5d8ea097081e2ea495_D20220303-20220303" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjllYjBiMmZlNmRhYTRiM2I5YjM3NzQzNjE4MzY1NDI2L3NlYzo5ZWIwYjJmZTZkYWE0YjNiOWIzNzc0MzYxODM2NTQyNl8xL2ZyYWc6YTM5M2Y1ODY2NGMxNDMwYWE1MWMxZWNhN2RiZTk2YTMvdGV4dHJlZ2lvbjphMzkzZjU4NjY0YzE0MzBhYTUxYzFlY2E3ZGJlOTZhM18yNzMw_06e84ef3-370c-43c2-add4-4846801db5f5">Concert Pharmaceuticals, Inc.</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.959%"><tr><td style="width:1.0%"></td><td style="width:32.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.146%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.993%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.155%"></td><td style="width:0.1%"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9531e69443c44d5d8ea097081e2ea495_D20220303-20220303" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjllYjBiMmZlNmRhYTRiM2I5YjM3NzQzNjE4MzY1NDI2L3NlYzo5ZWIwYjJmZTZkYWE0YjNiOWIzNzc0MzYxODM2NTQyNl8xL2ZyYWc6YTM5M2Y1ODY2NGMxNDMwYWE1MWMxZWNhN2RiZTk2YTMvdGFibGU6YzE2ZTNlMmY2NzgwNDhiY2I2MTdjZmNmZTA2NTU3YzgvdGFibGVyYW5nZTpjMTZlM2UyZjY3ODA0OGJjYjYxN2NmY2ZlMDY1NTdjOF8xLTAtMS0xLTEzOTE2_74eea321-63dd-411e-82c7-2ba5b911ede3">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9531e69443c44d5d8ea097081e2ea495_D20220303-20220303" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjllYjBiMmZlNmRhYTRiM2I5YjM3NzQzNjE4MzY1NDI2L3NlYzo5ZWIwYjJmZTZkYWE0YjNiOWIzNzc0MzYxODM2NTQyNl8xL2ZyYWc6YTM5M2Y1ODY2NGMxNDMwYWE1MWMxZWNhN2RiZTk2YTMvdGFibGU6YzE2ZTNlMmY2NzgwNDhiY2I2MTdjZmNmZTA2NTU3YzgvdGFibGVyYW5nZTpjMTZlM2UyZjY3ODA0OGJjYjYxN2NmY2ZlMDY1NTdjOF8xLTItMS0xLTEzOTE2_d3dcf12f-7d94-4811-81f4-0e8b71cccc4d">001-36310</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9531e69443c44d5d8ea097081e2ea495_D20220303-20220303" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjllYjBiMmZlNmRhYTRiM2I5YjM3NzQzNjE4MzY1NDI2L3NlYzo5ZWIwYjJmZTZkYWE0YjNiOWIzNzc0MzYxODM2NTQyNl8xL2ZyYWc6YTM5M2Y1ODY2NGMxNDMwYWE1MWMxZWNhN2RiZTk2YTMvdGFibGU6YzE2ZTNlMmY2NzgwNDhiY2I2MTdjZmNmZTA2NTU3YzgvdGFibGVyYW5nZTpjMTZlM2UyZjY3ODA0OGJjYjYxN2NmY2ZlMDY1NTdjOF8xLTQtMS0xLTEzOTE2_496cd8c2-5e15-4b78-84c2-fbcca717de91">20-4839882</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">(State or other jurisdiction<br/>of incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">(Commission<br/>File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">(IRS Employer<br/>Identification No.)</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9531e69443c44d5d8ea097081e2ea495_D20220303-20220303" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjllYjBiMmZlNmRhYTRiM2I5YjM3NzQzNjE4MzY1NDI2L3NlYzo5ZWIwYjJmZTZkYWE0YjNiOWIzNzc0MzYxODM2NTQyNl8xL2ZyYWc6YTM5M2Y1ODY2NGMxNDMwYWE1MWMxZWNhN2RiZTk2YTMvdGFibGU6ZDY2MGU2NTE5NmE2NDNmMjg1YTMwMTBmZGQ2YjFkODUvdGFibGVyYW5nZTpkNjYwZTY1MTk2YTY0M2YyODVhMzAxMGZkZDZiMWQ4NV8wLTAtMS0xLTEzOTE2L3RleHRyZWdpb246YjM1ODdmYjM1Y2QxNDQ4M2FlOTA2MmI0ZDc1N2IwODJfOQ_f341bb2b-5a8b-412c-bab8-3ee01d44f768">65 Hayden Avenue</ix:nonNumeric>, <ix:nonNumeric contextRef="i9531e69443c44d5d8ea097081e2ea495_D20220303-20220303" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOjllYjBiMmZlNmRhYTRiM2I5YjM3NzQzNjE4MzY1NDI2L3NlYzo5ZWIwYjJmZTZkYWE0YjNiOWIzNzc0MzYxODM2NTQyNl8xL2ZyYWc6YTM5M2Y1ODY2NGMxNDMwYWE1MWMxZWNhN2RiZTk2YTMvdGFibGU6ZDY2MGU2NTE5NmE2NDNmMjg1YTMwMTBmZGQ2YjFkODUvdGFibGVyYW5nZTpkNjYwZTY1MTk2YTY0M2YyODVhMzAxMGZkZDZiMWQ4NV8wLTAtMS0xLTEzOTE2L3RleHRyZWdpb246YjM1ODdmYjM1Y2QxNDQ4M2FlOTA2MmI0ZDc1N2IwODJfMTM_a2030145-1f9e-4fe4-8fe9-beb1268c044e">Suite 3000N</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9531e69443c44d5d8ea097081e2ea495_D20220303-20220303" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjllYjBiMmZlNmRhYTRiM2I5YjM3NzQzNjE4MzY1NDI2L3NlYzo5ZWIwYjJmZTZkYWE0YjNiOWIzNzc0MzYxODM2NTQyNl8xL2ZyYWc6YTM5M2Y1ODY2NGMxNDMwYWE1MWMxZWNhN2RiZTk2YTMvdGFibGU6ZDY2MGU2NTE5NmE2NDNmMjg1YTMwMTBmZGQ2YjFkODUvdGFibGVyYW5nZTpkNjYwZTY1MTk2YTY0M2YyODVhMzAxMGZkZDZiMWQ4NV8wLTAtMS0xLTEzOTE2L3RleHRyZWdpb246YjM1ODdmYjM1Y2QxNDQ4M2FlOTA2MmI0ZDc1N2IwODJfMTY_dccc21ac-761c-4462-9d2c-7abe85c6ddec">Lexington</ix:nonNumeric>, <ix:nonNumeric contextRef="i9531e69443c44d5d8ea097081e2ea495_D20220303-20220303" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjllYjBiMmZlNmRhYTRiM2I5YjM3NzQzNjE4MzY1NDI2L3NlYzo5ZWIwYjJmZTZkYWE0YjNiOWIzNzc0MzYxODM2NTQyNl8xL2ZyYWc6YTM5M2Y1ODY2NGMxNDMwYWE1MWMxZWNhN2RiZTk2YTMvdGFibGU6ZDY2MGU2NTE5NmE2NDNmMjg1YTMwMTBmZGQ2YjFkODUvdGFibGVyYW5nZTpkNjYwZTY1MTk2YTY0M2YyODVhMzAxMGZkZDZiMWQ4NV8wLTAtMS0xLTEzOTE2L3RleHRyZWdpb246YjM1ODdmYjM1Y2QxNDQ4M2FlOTA2MmI0ZDc1N2IwODJfMjA_b0eae20b-78cd-4229-8f89-5fcaf1606306">Massachusetts</ix:nonNumeric>   </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;&#160;&#160;<ix:nonNumeric contextRef="i9531e69443c44d5d8ea097081e2ea495_D20220303-20220303" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjllYjBiMmZlNmRhYTRiM2I5YjM3NzQzNjE4MzY1NDI2L3NlYzo5ZWIwYjJmZTZkYWE0YjNiOWIzNzc0MzYxODM2NTQyNl8xL2ZyYWc6YTM5M2Y1ODY2NGMxNDMwYWE1MWMxZWNhN2RiZTk2YTMvdGFibGU6ZDY2MGU2NTE5NmE2NDNmMjg1YTMwMTBmZGQ2YjFkODUvdGFibGVyYW5nZTpkNjYwZTY1MTk2YTY0M2YyODVhMzAxMGZkZDZiMWQ4NV8wLTEtMS0xLTEzOTE2_e3d58b62-e4b1-4f2e-8419-0d229595bb83">02421</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;(Zip Code)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Registrant&#8217;s telephone number, including area code: (<ix:nonNumeric contextRef="i9531e69443c44d5d8ea097081e2ea495_D20220303-20220303" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjllYjBiMmZlNmRhYTRiM2I5YjM3NzQzNjE4MzY1NDI2L3NlYzo5ZWIwYjJmZTZkYWE0YjNiOWIzNzc0MzYxODM2NTQyNl8xL2ZyYWc6YTM5M2Y1ODY2NGMxNDMwYWE1MWMxZWNhN2RiZTk2YTMvdGV4dHJlZ2lvbjphMzkzZjU4NjY0YzE0MzBhYTUxYzFlY2E3ZGJlOTZhM18yNzQx_ed08bea0-5b2d-4df1-8aff-2e3e1f28b84f">781</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="i9531e69443c44d5d8ea097081e2ea495_D20220303-20220303" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjllYjBiMmZlNmRhYTRiM2I5YjM3NzQzNjE4MzY1NDI2L3NlYzo5ZWIwYjJmZTZkYWE0YjNiOWIzNzc0MzYxODM2NTQyNl8xL2ZyYWc6YTM5M2Y1ODY2NGMxNDMwYWE1MWMxZWNhN2RiZTk2YTMvdGV4dHJlZ2lvbjphMzkzZjU4NjY0YzE0MzBhYTUxYzFlY2E3ZGJlOTZhM18yNzMx_a8040328-5aa8-4952-a52d-589b426ba9fd">860-0045</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Former name or former address, if changed since last report)</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">see</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;General Instruction A.2. below):</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9531e69443c44d5d8ea097081e2ea495_D20220303-20220303" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjllYjBiMmZlNmRhYTRiM2I5YjM3NzQzNjE4MzY1NDI2L3NlYzo5ZWIwYjJmZTZkYWE0YjNiOWIzNzc0MzYxODM2NTQyNl8xL2ZyYWc6YTM5M2Y1ODY2NGMxNDMwYWE1MWMxZWNhN2RiZTk2YTMvdGV4dHJlZ2lvbjphMzkzZjU4NjY0YzE0MzBhYTUxYzFlY2E3ZGJlOTZhM18yNzMz_e66e7ae8-cfbf-4f79-ab22-910a67ab8855">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9531e69443c44d5d8ea097081e2ea495_D20220303-20220303" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjllYjBiMmZlNmRhYTRiM2I5YjM3NzQzNjE4MzY1NDI2L3NlYzo5ZWIwYjJmZTZkYWE0YjNiOWIzNzc0MzYxODM2NTQyNl8xL2ZyYWc6YTM5M2Y1ODY2NGMxNDMwYWE1MWMxZWNhN2RiZTk2YTMvdGV4dHJlZ2lvbjphMzkzZjU4NjY0YzE0MzBhYTUxYzFlY2E3ZGJlOTZhM18yNzQy_f69fca26-154e-4814-80b5-0102ccab5adc">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9531e69443c44d5d8ea097081e2ea495_D20220303-20220303" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjllYjBiMmZlNmRhYTRiM2I5YjM3NzQzNjE4MzY1NDI2L3NlYzo5ZWIwYjJmZTZkYWE0YjNiOWIzNzc0MzYxODM2NTQyNl8xL2ZyYWc6YTM5M2Y1ODY2NGMxNDMwYWE1MWMxZWNhN2RiZTk2YTMvdGV4dHJlZ2lvbjphMzkzZjU4NjY0YzE0MzBhYTUxYzFlY2E3ZGJlOTZhM18yNzM4_2e1d75c9-14e6-474f-a63f-20388fa7766a">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9531e69443c44d5d8ea097081e2ea495_D20220303-20220303" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjllYjBiMmZlNmRhYTRiM2I5YjM3NzQzNjE4MzY1NDI2L3NlYzo5ZWIwYjJmZTZkYWE0YjNiOWIzNzc0MzYxODM2NTQyNl8xL2ZyYWc6YTM5M2Y1ODY2NGMxNDMwYWE1MWMxZWNhN2RiZTk2YTMvdGV4dHJlZ2lvbjphMzkzZjU4NjY0YzE0MzBhYTUxYzFlY2E3ZGJlOTZhM18yNzQ0_018849c9-2695-4789-a53c-b7789f2470ab">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act: </span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.439%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.743%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9531e69443c44d5d8ea097081e2ea495_D20220303-20220303" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjllYjBiMmZlNmRhYTRiM2I5YjM3NzQzNjE4MzY1NDI2L3NlYzo5ZWIwYjJmZTZkYWE0YjNiOWIzNzc0MzYxODM2NTQyNl8xL2ZyYWc6YTM5M2Y1ODY2NGMxNDMwYWE1MWMxZWNhN2RiZTk2YTMvdGFibGU6MzVmNmVhMGYzYmViNDdiZGE5Nzk2ZDg4NzNjNTI5NDYvdGFibGVyYW5nZTozNWY2ZWEwZjNiZWI0N2JkYTk3OTZkODg3M2M1Mjk0Nl8xLTAtMS0xLTEzOTE2_bffa54e9-464b-4452-b096-29aa5c31683e">Common stock, $0.001 par value per share</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9531e69443c44d5d8ea097081e2ea495_D20220303-20220303" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjllYjBiMmZlNmRhYTRiM2I5YjM3NzQzNjE4MzY1NDI2L3NlYzo5ZWIwYjJmZTZkYWE0YjNiOWIzNzc0MzYxODM2NTQyNl8xL2ZyYWc6YTM5M2Y1ODY2NGMxNDMwYWE1MWMxZWNhN2RiZTk2YTMvdGFibGU6MzVmNmVhMGYzYmViNDdiZGE5Nzk2ZDg4NzNjNTI5NDYvdGFibGVyYW5nZTozNWY2ZWEwZjNiZWI0N2JkYTk3OTZkODg3M2M1Mjk0Nl8xLTEtMS0xLTEzOTE2_86f9a416-4aba-4d7a-8f9d-6ee72622e3bd">CNCE</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9531e69443c44d5d8ea097081e2ea495_D20220303-20220303" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjllYjBiMmZlNmRhYTRiM2I5YjM3NzQzNjE4MzY1NDI2L3NlYzo5ZWIwYjJmZTZkYWE0YjNiOWIzNzc0MzYxODM2NTQyNl8xL2ZyYWc6YTM5M2Y1ODY2NGMxNDMwYWE1MWMxZWNhN2RiZTk2YTMvdGFibGU6MzVmNmVhMGYzYmViNDdiZGE5Nzk2ZDg4NzNjNTI5NDYvdGFibGVyYW5nZTozNWY2ZWEwZjNiZWI0N2JkYTk3OTZkODg3M2M1Mjk0Nl8xLTItMS0xLTEzOTE2_0032f448-ded3-470d-935f-5065acd40527">Nasdaq Global Market</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2). </span></div><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9531e69443c44d5d8ea097081e2ea495_D20220303-20220303" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjllYjBiMmZlNmRhYTRiM2I5YjM3NzQzNjE4MzY1NDI2L3NlYzo5ZWIwYjJmZTZkYWE0YjNiOWIzNzc0MzYxODM2NTQyNl8xL2ZyYWc6YTM5M2Y1ODY2NGMxNDMwYWE1MWMxZWNhN2RiZTk2YTMvdGV4dHJlZ2lvbjphMzkzZjU4NjY0YzE0MzBhYTUxYzFlY2E3ZGJlOTZhM18yNzM2_da2cab57-01b6-4191-a19c-a2caf4b1b872">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#168;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item&#160;2.02. Results of Operations and Financial Condition.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">On <ix:nonNumeric contextRef="i9531e69443c44d5d8ea097081e2ea495_D20220303-20220303" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjllYjBiMmZlNmRhYTRiM2I5YjM3NzQzNjE4MzY1NDI2L3NlYzo5ZWIwYjJmZTZkYWE0YjNiOWIzNzc0MzYxODM2NTQyNl8xL2ZyYWc6YTM5M2Y1ODY2NGMxNDMwYWE1MWMxZWNhN2RiZTk2YTMvdGV4dHJlZ2lvbjphMzkzZjU4NjY0YzE0MzBhYTUxYzFlY2E3ZGJlOTZhM18xNjQ5MjY3NDQ0NDE1_52da2b14-28ba-428f-a14f-1de4353c003d">March&#160;3, 2022</ix:nonNumeric>, Concert Pharmaceuticals, Inc. announced its financial results for the quarter and year ended December&#160;31, 2021. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K.</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The information in this Current Report on Form 8-K and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item&#160;9.01. Financial Statements and Exhibits.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:4.02pt">Exhibits</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:15.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:76.793%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Description</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline" href="q42021earningsrelease.htm">99.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline" href="q42021earningsrelease.htm">Press release issued by the Registrant on March 3, 2022</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SIGNATURE</span></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.277%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">CONCERT PHARMACEUTICALS, INC.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9531e69443c44d5d8ea097081e2ea495_D20220303-20220303" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjllYjBiMmZlNmRhYTRiM2I5YjM3NzQzNjE4MzY1NDI2L3NlYzo5ZWIwYjJmZTZkYWE0YjNiOWIzNzc0MzYxODM2NTQyNl8xL2ZyYWc6YTM5M2Y1ODY2NGMxNDMwYWE1MWMxZWNhN2RiZTk2YTMvdGFibGU6ZWNmM2RjODliYmM0NDQ5N2I2YmI2NzE4YjczODU1Y2MvdGFibGVyYW5nZTplY2YzZGM4OWJiYzQ0NDk3YjZiYjY3MThiNzM4NTVjY18zLTEtMS0xLTEzOTE2_52da2b14-28ba-428f-a14f-1de4353c003d">March 3, 2022</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">/s/ Jeffrey A. Munsie</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Jeffrey A. Munsie</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Chief Legal Officer</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
[{"type": "8-K", "sequence": "1", "filename": "cnce-20220303.htm", "description": "8-K", "secsgml_size_bytes": 39654}]
{"company-data": {"conformed-name": "CONCERT PHARMACEUTICALS, INC.", "cik": "0001367920", "assigned-sic": "2834", "irs-number": "000000000", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-36310", "film-number": "22706642"}, "business-address": {"street1": "65 HAYDEN AVENUE", "street2": "SUITE 3000N", "city": "LEXINGTON", "state": "MA", "zip": "02421", "phone": "781-860-0045"}, "mail-address": {"street1": "65 HAYDEN AVENUE", "street2": "SUITE 3000N", "city": "LEXINGTON", "state": "MA", "zip": "02421"}, "former-company": {"former-conformed-name": "CONCERT PHARMACEUTICALS INC", "date-changed": "20060628"}}
cnce-20220303
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________________________
FORM
8-K
_________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
March 3, 2022
Concert Pharmaceuticals, Inc.
(Exact name of registrant as specified in its charter)
Delaware
001-36310
20-4839882
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
65 Hayden Avenue
,
Suite 3000N
Lexington
,
Massachusetts
02421
(Address of principal executive offices)
(Zip Code)
Registrant's telephone number, including area code: (
781
)
860-0045
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (
see
General Instruction A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common stock, $0.001 par value per share
CNCE
Nasdaq Global Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
¨
Item 2.02. Results of Operations and Financial Condition.
On
March 3, 2022
, Concert Pharmaceuticals, Inc. announced its financial results for the quarter and year ended December 31, 2021. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The information in this Current Report on Form 8-K and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Item 9.01. Financial Statements and Exhibits.
(d)
Exhibits
Exhibit No.
Description
99.1
Press release issued by the Registrant on March 3, 2022
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
CONCERT PHARMACEUTICALS, INC.
Date:
March 3, 2022
By:
/s/ Jeffrey A. Munsie
Jeffrey A. Munsie
Chief Legal Officer